Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

This study examined the activity and safety of amrubicin monotherapy among relapsed small-cell lung cancer (SCLC) patients who had previously been treated with atezolizumab plus carboplatin and etoposide (AteCE). This retrospective study evaluated patients with relapsed SCLC who were treated with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Nagai, Yoshiaki, Minemura, Hiroyuki, Tsuda, Takeshi, Yamada, Yutaka, Wasamoto, Satoshi, Kishikawa, Takayuki, Shiono, Ayako, Shiihara, Jun, Yamaguchi, Ou, Mouri, Atsuto, Kaira, Kyoichi, Kanazawa, Kenya, Taniguchi, Hirokazu, Minato, Koichi, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395483/
https://www.ncbi.nlm.nih.gov/pubmed/35749041
http://dx.doi.org/10.1007/s10637-022-01269-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395483/
https://www.ncbi.nlm.nih.gov/pubmed/35749041
http://dx.doi.org/10.1007/s10637-022-01269-9

Ejemplares similares